BMS-986326

DRUG3 trials

Sponsors

Bristol-Myers Squibb

Conditions

Dermatitis, AtopicHealthy ParticipantsLupus

Phase 1

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Healthy Participants

CompletedNCT04736134

Bristol-Myers SquibbHealthy Participants

Start: 2021-03-03End: 2024-03-14Updated: 2024-05-06

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

CompletedNCT06013995

Bristol-Myers SquibbLupus

Start: 2023-09-21End: 2026-04-14Updated: 2026-05-26

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

CompletedNCT06248814

Bristol-Myers SquibbDermatitis, Atopic

Start: 2024-03-06End: 2025-11-06Updated: 2025-12-08